Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
4DMT restructures pipeline, extending cash runway through 2028
4DMT is axing two clinical programs and shutting off funds for three other assets, with resources to be pivoted toward gene therapy 4D-150.
Gabrielle Masson
Jan 10, 2025 2:00pm
AbbVie exercises $40M option for Capsida-partnered gene therapy
Jan 7, 2025 10:45am
Vertex and Orna team up to develop new blood disorder treatments
Jan 7, 2025 7:00am
AI firm launches US lab, welcomes new CSO and computer cluster
Jan 6, 2025 6:00am
Regeneron snaps up eye biotech, snaring science but not staff
Jan 2, 2025 3:58pm
Pfizer crashes Sangamo's stock by ending hem A gene therapy pact
Jan 2, 2025 6:08am